51
Participants
Start Date
January 1, 2018
Primary Completion Date
March 31, 2019
Study Completion Date
March 31, 2019
Nebivolol
Patients are randomly assigned to a ratio of 1: 1: 1, divided into 3 groups.
Diltiazem
Patients are randomly assigned to a ratio of 1: 1: 1, divided into 3 groups.
Nebivolol+Diltiazem
Patients are randomly assigned to a ratio of 1: 1: 1, divided into 3 groups.
Korea University Anam Hospital, Seoul
Korea University Guro Hospital
OTHER
Korea University Ansan Hospital
OTHER
Severance Hospital
OTHER
Korea University Anam Hospital
OTHER